Home Top Movers Does this key event move Imara Inc.'s stock (Nasdaq: IMRA) in the...

Does this key event move Imara Inc.’s stock (Nasdaq: IMRA) in the morning session?

Imara Inc. (Nasdaq: IMRA) is a biotech, clinical-stage firm dedicated to making and selling therapy to treat patients with rare genetic disorders of hemoglobin (Hb).

Imara Inc. (Nasdaq: IMRA), shares dropped -32.57% to $16.00 in the early morning session after the company announced findings from its phase 2a IMR-687 clinical trial in adult sickle cell disease patients (SCD).

The Phase 2a clinical trial consisted of 93 treatments in four sub-studies. It was planned to assess efficacy, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and clinical effects of increased IMR-687 doses once daily for 16 to 24 weeks, whether as a monotherapy or in conjunction with hydroxyurea (HU).

Overall, phase 2a clinical results show that IMR-687 has been well-tolerated following HU at all dosage ranges as a monotherapy. No clinically significant changes in vital signs or electrocardiogram data were observed, including no hypotension or neutropenia in either the monotherapy arms or the combination arms. Prior interim results were published on Populations A and B patients, with A1 and B1 populations being reported for the first time.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Prompted INVO Biosciences’ After-Hours Rally?

A spike in INVO Bioscience, Inc's (NASDAQ: INVO) stock price after-hours drove its price up 83.28% on Monday. In regular sessions, through the end...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

Tron (TRX) Working Hard on DeFi Development; Where is TRX Heading?

Tron 2021 Global DeFi Hackathon developer contest is one of its $120 million TRON DeFi Entrepreneurial Alliance Support Program.  TRON (TRX) is making sure that it...

Mark Cuban backs Dogecoin (DOGE) and says Dallas Mavericks are the largest merchant of Meme Coin worldwide

After Elon Musk, Cuban comes out in favor of the meme coin. Dogecoin (DOGE) is one of the most anticipated cryptocurrencies of the future. Back...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Related News

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Is Xpresspa (XSPA) Rocketing 16% Before Market Open Today?

The global health and wellness company XpresSpa Group, Inc. (Nasdaq: XSPA) has been seeing stock rising 16.05% (as of 08:10 a.m. EST) in pre-market...

What Gave GEVO Stock A 9% Boost In Aftermarket Trading On Friday?

Gevo, Inc. (NASDAQ: GEVO) shares risen by 9.46% on Friday in after-hours trading, rising the stock price to $7.64. The company saw its stock...

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Evofem Biosciences (EVFM) – Stock Fell In Early Trades Today: Why?

Shares of the biopharmaceutical company Evofem Biosciences, Inc., (NASDAQ: EVFM) have been sinking in the early trades today. The stock was buoying at $2.205...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.